Literature DB >> 6276911

Stress-induced plasma beta-endorphin immunoreactivity may predict postoperative morphine usage.

M R Cohen, D Pickar, M Dubois, W E Bunney.   

Abstract

The relationship between stress and human behavior is studied using general surgery as a stress paradigm. As indices of arousal, presurgery and surgery plasma beta-endorphin and cortisol immunoreactivity are assessed. Behavioral analysis is restricted to the measurement of total morphine usage during the first 24 postoperative hours under standard PRN (as needed) clinical orders. Individual patient morphine requirements vary widely (12-56 mg). Both presurgery and mean surgery plasma beta-endorphin levels significantly predict morphine requirement, and similar, although not so strong, correlations are found for cortisol. Patient age is also found to be negatively correlated with morphine requirement. When multiple regression analysis is used, the variables of plasma beta-endorphin and age predict 70% of the variance in individual morphine requirements.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6276911     DOI: 10.1016/0165-1781(82)90032-4

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  5 in total

1.  Effects of bupivacaine infiltration on beta-endorphin and cortisol release and postoperative pain following inguinal herniorrhaphy in children.

Authors:  H Okur; M Küçükaydin; S Muhtaroğlu; A Kazez
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

2.  Do Resting Plasma β-Endorphin Levels Predict Responses to Opioid Analgesics?

Authors:  Stephen Bruehl; John W Burns; Rajnish Gupta; Asokumar Buvanendran; Melissa Chont; Daria Orlowska; Erik Schuster; Christopher R France
Journal:  Clin J Pain       Date:  2017-01       Impact factor: 3.442

3.  What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function?

Authors:  S Bruehl; J W Burns; O Y Chung; M Chont
Journal:  Eur J Pain       Date:  2011-12-19       Impact factor: 3.931

Review 4.  Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology.

Authors:  Kyriaki Mystakidou; Eleni Tsilika; Marinos Tsiatas; Lambros Vlahos
Journal:  Int J Nanomedicine       Date:  2007

5.  A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study.

Authors:  Ersilia Lucenteforte; Laura Vagnoli; Alessandra Pugi; Giada Crescioli; Niccolò Lombardi; Roberto Bonaiuti; Maurizio Aricò; Sabrina Giglio; Andrea Messeri; Alessandro Mugelli; Alfredo Vannacci; Valentina Maggini
Journal:  BMC Cancer       Date:  2018-05-18       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.